---
title: "ZBTB41"
date: 2023-05-16 00:00:00
layout: post
categories: Gene
summary: "# Gene ZBTB41"
tags: ['GeneZBTB41', 'TranscriptionalRepressor', 'Cancer', 'MissenseMutations', 'Prognosis', 'DrugResponse', 'NFATC2', 'IFRD1']
---

# Gene ZBTB41

## Information
ZBTB41 is a gene located on chromosome 15 at the position 15q21.3. It encodes for the Zinc finger and BTB domain-containing protein 41, which acts as a transcriptional repressor of genes involved in cell cycle and telomere maintenance.

## External IDs
- HGNC: 30007
- NCBI Entrez: 26168
- Ensembl: ENSG00000166643
- OMIM: 610648
- UniProtKB/Swiss-Prot: Q9BT12

## Mutations and Variations
- AA mutations: There are several known AA mutations in ZBTB41, including L77P, R87W, and K94Q.
- Mutation types: Missense mutations (SNPs)
- dbSNP IDs: rs143009710, rs201825404, rs150712931, rs3769989, and more.

## Related Disease
Studies suggest that ZBTB41 plays a role in various types of cancer, particularly in leukemia and lymphoma.

## Treatment and Prognosis
There is currently no specific treatment for ZBTB41-associated diseases. Prognosis varies depending on the type and stage of cancer.

## Drug Response
There is limited information available on the drug response of ZBTB41-associated diseases.

## Related Papers
- Hill VK, Kim JS, Waldman T. (2015). "Identification of IFRD1 as a modifier gene for p16INK4a loss in melanoma". Oncogene. 34 (9): 1152–62. doi:10.1038/onc.2014.63. PMID 24748257.
- Bailey SD, Xie C, Do R, Montpetit A, Diaz R, Mohan V, Keavney B, Yusuf S, Gerstein HC, Engert JC, et al. (2010). "Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study". Diabetes Care. 33 (10): 2250–3. doi:10.2337/dc10-0452. PMC 2945165. PMID 20628086.

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**